Antimalarial Drug Resistance and Implications for the WHO Global Technical Strategy-Reference-Cited by-同舟云学术

Antimalarial Drug Resistance and Implications for the WHO Global Technical Strategy

Published:2021-03-14 Issue:2 Volume:8 Page:46-62
ISSN:2196-2995
Container-title:Current Epidemiology Reports
language:en
Short-container-title:Curr Epidemiol Rep

Author:

Ippolito Matthew M.,Moser Kara A.,Kabuya Jean-Bertin Bukasa,Cunningham Clark,Juliano Jonathan J.

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40471-021-00266-5.pdf

Reference237 articles.

1. World Health Organization. Official records of the World Health Organization No. 184, 23rd World Health Assembly: Geneva, World Health Organization; 1970.

2. Najera JA, Gonzalez-Silva M, Alonso PL. Some lessons for the future from the Global Malaria Eradication Programme (1955-1969). PLoS Med. 2011;8(1):e1000412.

3. World Health Organization Expert Committee on Malaria Technical Report Series No. 357: World Health Organization Expert Committee on Malaria 13th Report. Geneva: World Health Organization; 1967.

4. World Health Organization. Global technical strategy for malaria 2016-2030. Geneva: World Health Organization; 2016.

5. World Health Organization. World malaria report. Geneva: WHO Global Malaria Programme; 2019.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The design, synthesis and antiplasmodial evaluation of novel sulfoximine-isoxazole hybrids as potential antimalarial agents;European Journal of Medicinal Chemistry Reports;2024-04

2. Redox modulating small molecules having antimalarial efficacy;Biochemical Pharmacology;2023-12

3. China’s hidden role in malaria control and elimination in Africa;BMJ Global Health;2023-12

4. Prophylaxis Failure and Successful Management of Delayed-Onset Malaria with Renal Complications: A Case Report with Oral Artemether-Lumefantrine Treatment;Reports;2023-11-08

5. Genetic validation of PfFKBP35 as an antimalarial drug target;eLife;2023-11-07